373 publications

Name Date Type Actions

Déclaration liée à la réalisation d’un programme de rachats d’actions - Période du 18 au 22 février 2008 (french)

 		03/03/2008 Monthly communication regarding buyback programs

VÉTOQUINOL S.A. and JUROX PTY LTD extend their collaboration on ALFAXAN® in Europe

 		17/03/2008 Public releases

Earnings for 2007 attest to strength of business growth model

The Vétoquinol board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements. In 2007, Vétoquinol once again achieved significant improvement in its key performance
indicators, ahead of its medium-term targets. According to the most recent statistics published by Vetnosis, this substantial rise in revenue has lifted Vétoquinol to third place
worldwide.

 		18/03/2008 Public releases

Programme de rachat - mars 2008 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

 		17/04/2008 Monthly communication regarding buyback programs

Programme de rachat - avril 2008 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

 		01/05/2008 Monthly communication regarding buyback programs

Satisfactory revenue growth for 1st quarter 2008: +4.6% on a constant basis

Revenue for the first quarter of 2008 reached €54.7 M, an increase of 3.0% over the first quarter of 2007, a high revenue growth period. First quarter 2008 growth was particularly significant for the livestock segment.

 		06/05/2008 Public releases

Programme de rachat - mai 2008 (french)

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

 		31/05/2008 Monthly communication regarding buyback programs

Vétoquinol strengthens its presence in Canada in the compagnion animal market

Vétoquinol announces the acquisition of the animal health business assets of VETCOM 1979 INC. The animal health business of VETCOM 1979 INC. includes annual revenue of around CAD1.5 million. The company covers nearly 65% of the market for ophthalmological unguents in Canada.

 		01/07/2008 Public releases

Pierre Konareff est nommé Directeur Financier et Juridique du Groupe Vétoquinol (french)

Vétoquinol annonce la nomination de Pierre Konareff au poste de Directeur Financier et Juridique du groupe.

 		08/07/2008 Public releases

2008 Interim Revenues increase by 5%

Vétoquinol generated revenues of 116.7 million euros in the first half of 2008, a 5% increase over the 111.1 million euros
reported the previous year.

 		22/07/2008 Public releases